$ Value
—
Shares
7,111
Price
—
Filed
May 20
Insider
Name
DArecca James
Title
EVP, Chief Financial Officer
CIK
0001583903
Roles
Transaction Details
Transaction Date
2025-05-16
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,935
Footnotes
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. | This number includes unvested RSUs previously reported. | Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Filing Info
DArecca James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-05 | PBH | A | $0 |
| 2025-05-30 | HAE | A | $0 |
| 2025-05-30 | HAE | F | $407K |
| 2025-05-16 | HAE | F | $88K |
| 2025-05-16 | HAE | A | — |
| 2025-05-16 | HAE | A | $0 |
| 2025-05-15 | HAE | F | $43K |
| 2025-05-02 | HAE | F | $42K |
Other Insiders at HAE (90d)
No other insider activity at this issuer in the last 90 days.